MMP2 and neoplasm: Talvensaari-Mattila et al. explored the role of MMP-2 as a prognostic factor, and proved (by examining tumor samples taken from 453 patients) that decreased concentration of MMP-2 can serve as a marker for favorable prognosis in breast cancer [50].